The appropriate use of drugs in any situation, whether you're talking about human drugs or veterinary drugs, is a shared responsibility. Industry has the responsibility to develop drugs that are safe and efficacious. Health Canada's responsibility is to review that information, evaluate, and make a decision as to whether those drugs are issued a notice of compliance and put on the market.
Veterinarians, as well as physicians, when you look at human drugs, have the responsibility to use these drugs appropriately. That's the reason for having our package inserts and the information that accompanies a drug when it is marketed in Canada. There is information there. There are systems in place. Obviously, CFIA does monitoring of residues, and where there is an issue, these things are followed up.
So I think we need to look at this as a real, shared responsibility. That's the reason why, when we look at a lot of our policy initiatives, when we look at personal use importation, and when we look at off-label use of drugs, which is when drugs are approved for one species and used in another, CDMA is also at the table. It is so they understand that they also have a responsibility.